Cancer and central nervous system disorders: protocol for an umbrella review of systematic reviews and updated meta-analyses of observational studies
Authors:
- Ferrán Catalá-LópezFCFerrán Catalá-López
- Brian HuttonBHBrian Hutton
- Jane A. DriverJDJane A. Driver
- Matthew J. PageMPMatthew J. Page
- Manuel RidaoMRManuel Ridao
- José M. ValderasJVJosé M. Valderas
- Adolfo Alonso-ArroyoAAAdolfo Alonso-Arroyo
- Jaume Forés-MartosJFJaume Forés-Martos
- Salvador MartínezSalvador Martínez
- Ricard Gènova-MalerasRGRicard Gènova-Maleras
- Diego Macías-Saint-GeronsDMDiego Macías-Saint-Gerons
- Benedicto Crespo-FacorroBCBenedicto Crespo-Facorro
Open Access
- 4 April 2017
- journal article
- review article
- Published by Springer Nature in Systematic Reviews
- Vol. 6 (1) , 1-8
Abstract
The objective of this study will be to synthesize the epidemiological evidence and evaluate the validity of the associations between central nervous system disorders and the risk of developing or dying from cancer. We will perform an umbrella review of systematic reviews and conduct updated meta-analyses of observational studies (cohort and case-control) investigating the association between central nervous system disorders and the risk of developing or dying from any cancer or specific types of cancer. Searches involving PubMed/MEDLINE, EMBASE, SCOPUS and Web of Science will be used to identify systematic reviews and meta-analyses of observational studies. In addition, online databases will be checked for observational studies published outside the time frames of previous reviews. Eligible central nervous system disorders will be Alzheimer’s disease, anorexia nervosa, amyotrophic lateral sclerosis, autism spectrum disorders, bipolar disorder, depression, Down’s syndrome, epilepsy, Huntington’s disease, multiple sclerosis, Parkinson’s disease and schizophrenia. The primary outcomes will be cancer incidence and cancer mortality in association with a central nervous system disorder. Secondary outcome measures will be site-specific cancer incidence and mortality, respectively. Two reviewers will independently screen references identified by the literature search, as well as potentially relevant full-text articles. Data will be abstracted, and study quality/risk of bias will be appraised by two reviewers independently. Conflicts at all levels of screening and abstraction will be resolved through discussion. Random-effects meta-analyses of primary observational studies will be conducted where appropriate. Parameters for exploring statistical heterogeneity are pre-specified. The World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) criteria and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used for determining the quality of evidence for cancer outcomes. Our study will establish the extent of the epidemiological evidence underlying the associations between central nervous system disorders and cancer and will provide a rigorous and updated synthesis of a range of important site-specific cancer outcomes. PROSPERO CRD42016052762Keywords
Funding Information
- Generalitat Valenciana (PROMETEOII/2015/021)
- Centro de Investigación Biomédica en Red de Salud Mental (Intramural 2015)
This publication has 68 references indexed in Scilit:
- Comparative effectiveness of monotherapies and combination therapies for patients with hypertension: protocol for a systematic review with network meta-analysesSystematic Reviews, 2013
- Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional studyThe Lancet, 2012
- Meta-analysis of the relationship between Parkinson disease and melanomaNeurology, 2011
- Methodology in conducting a systematic review of systematic reviews of healthcare interventionsBMC Medical Research Methodology, 2011
- Cancer linked to Alzheimer disease but not vascular dementiaNeurology, 2010
- Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analysesCanadian Medical Association Journal, 2009
- A Re-Evaluation of Random-Effects Meta-AnalysisJournal of the Royal Statistical Society Series A: Statistics in Society, 2008
- GRADE: an emerging consensus on rating quality of evidence and strength of recommendationsBMJ, 2008
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986